Author(s): Miller AE
Abstract Share this page
Abstract The past decade has seen a surge of research interest in multiple sclerosis and an accelerated expansion of investigative efforts into multiple sclerosis therapeutics. Investigators have continued dissecting the complex immunological perturbations that may contribute to the disease and made major advances in understanding the genetics of multiple sclerosis. This article addresses current investigative issues and offers predictions about where the understanding and treatment of multiple sclerosis may stand at the end of the 21st century's second decade. © 2011 Mount Sinai School of Medicine.
This article was published in Mt Sinai J Med
and referenced in Journal of Molecular and Genetic Medicine